Does ECALLANTIDE Cause Product dose omission issue? 57 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 57 reports of Product dose omission issue have been filed in association with ECALLANTIDE (Kalbitor). This represents 4.7% of all adverse event reports for ECALLANTIDE.
57
Reports of Product dose omission issue with ECALLANTIDE
4.7%
of all ECALLANTIDE reports
1
Deaths
38
Hospitalizations
How Dangerous Is Product dose omission issue From ECALLANTIDE?
Of the 57 reports, 1 (1.8%) resulted in death, 38 (66.7%) required hospitalization, and 3 (5.3%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ECALLANTIDE. However, 57 reports have been filed with the FAERS database.
What Other Side Effects Does ECALLANTIDE Cause?
Hereditary angioedema (519)
Off label use (139)
Drug ineffective (89)
Malaise (60)
Headache (54)
Weight decreased (52)
Pain (50)
Weight increased (47)
Hypersensitivity (38)
Inappropriate schedule of product administration (38)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which ECALLANTIDE Alternatives Have Lower Product dose omission issue Risk?
ECALLANTIDE vs ECONAZOLE
ECALLANTIDE vs ECULIZUMAB
ECALLANTIDE vs EDARAVONE
ECALLANTIDE vs EDETATE
ECALLANTIDE vs EDOXABAN